Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AI-Assisted Remote Insulin Pump Optimization in T1DM

NCT: NCT07732777 · RECRUITING

NCT IDNCT07732777
StatusRECRUITING
Start Date2026-01-28
Completion2028-12-31
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (OTHER)
First posted
Last updated

Brief Summary

This study evaluates an AI-assisted remote parameter optimization tool for individuals with type 1 diabetes （T1D） using insulin pump and continuous glucose monitoring (CGM). The Artificial Intelligence (AI) algorithm analyzes regularly CGM and insulin data to generate personalized recommendations for adjusting pump settings. All algorithm-generated recommendations are reviewed and approved by physicians before being transmitted to the participant's mobile application for implementation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑